Diagnosticos da America (BSP:DASA3) Inventories, Other: R$3 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BSP:DASA3 Diagnosticos da America SA BSP:DASA3
46 GF Score
Price R$2.58
GF Value R$1.69
Valuation Significantly Overvalued
! 3 Warning Signs
View Full Analysis

What is Diagnosticos da America Inventories, Other?

Diagnosticos da America BSP:DASA3 +12.66% 46 Inventories, Other is R$3 Mil as of Jun. 2026. GuruFocus rates BSP:DASA3 with a GF Score™ of 46/100 and a GF Value™ of R$1.69 (Significantly Overvalued). The stock has 3 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. Diagnosticos da America's other inventories for the quarter that ended in Jun. 2026 was R$3 Mil.

Diagnosticos da America's quarterly other inventories declined from Dec. 2025 (R$190 Mil) to Mar. 2026 (R$2 Mil) but then increased from Mar. 2026 (R$2 Mil) to Jun. 2026 (R$3 Mil).

Diagnosticos da America's annual other inventories increased from Dec. 2023 (R$451 Mil) to Dec. 2024 (R$466 Mil) but then declined from Dec. 2024 (R$466 Mil) to Dec. 2025 (R$190 Mil).

Diagnosticos da America Inventories, Other Historical Data

* Premium members only.

The historical data trend for Diagnosticos da America's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diagnosticos da America Inventories, Other Chart

Diagnosticos da America Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 367.12 476.03 450.98 465.54 190.37

Diagnosticos da America Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 264.40 226.23 190.37 2.22 2.60
BSP:DASA3
46GF Score
Diagnosticos da America SA BSP:DASA3
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diagnosticos da America Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of R$3 Mil mean?
Diagnosticos da America (BSP:DASA3) has a Inventories, Other of R$3 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Diagnosticos da America and its competitors.
Is Diagnosticos da America's Inventories, Other too high?
Diagnosticos da America's current Inventories, Other is R$3 Mil. Overall, Diagnosticos da America has a GF Score™ of 46/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Diagnosticos da America's Inventories, Other compare to TMO and DHR?
Diagnosticos da America's Inventories, Other of R$3 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Medical Diagnostics & Research company?
A good Inventories, Other depends on the Medical Diagnostics & Research industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on Diagnosticos da America and its competitors. Diagnosticos da America's current Inventories, Other is R$3 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diagnosticos da America stock overvalued right now?
Based on GuruFocus' analysis, Diagnosticos da America (BSP:DASA3) is currently considered Significantly Overvalued. The stock's GF Value™ is R$1.69, compared to a current price of R$2.58 — trading 52.7% above its estimated fair value. The current Inventories, Other is R$3 Mil. Diagnosticos da America's overall GF Score™ is 46/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For Diagnosticos da America (BSP:DASA3), the current Inventories, Other is R$3 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diagnosticos da America (BSP:DASA3) Overvalued in 2026?

Based on GuruFocus' analysis, Diagnosticos da America stock appears to be overvalued. The current stock price of R$2.58 is trading 52.7% above its estimated GF Value™ of R$1.69. GuruFocus considers Diagnosticos da America to be Significantly Overvalued.

Key valuation signals for BSP:DASA3:

  • Inventories, Other: R$3 Mil
  • GF Value™: R$1.69 vs. price of R$2.58 (52.7% above fair value)
  • GF Score™: 46/100 with 3 warning signs

No single metric tells the full story. See the BSP:DASA3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Diagnosticos da America Business Description

Address Avenida Jurua, 434, Alphaville, Barueri, SP, BRA, 06455-010
Diagnosticos da America SA operates as a medical diagnostics company in Brazil. The company offers clinical analysis, diagnostic imaging tests, and patient service centers. It has three operating segments. Outpatient care services and care coordination includes Diagnosis and health management, Hospitals and oncology include Medical and hospital services & Foreign operations include Diagnosis. The majority is from the Hospitals and oncology segment. Geographically, it operates in Brazil and South America (Argentina, Uruguay, Chile and Colombia).
46GF Score

Get the complete analysis for BSP:DASA3

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R$2.58
Price
R$1.69
GF Value